EssilorLuxottica Société anonyme (EL.PA)
EUR 234.5
(0.51%)
EUR 234.5
(0.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 9.09 Billion EUR | -12.91% |
| 2022 | 10.44 Billion EUR | -8.58% |
| 2021 | 11.42 Billion EUR | 58.48% |
| 2020 | 7.21 Billion EUR | 57.48% |
| 2019 | 4.57 Billion EUR | 18.23% |
| 2018 | 3.87 Billion EUR | 423.38% |
| 2017 | 740 Million EUR | -64.64% |
| 2016 | 2.09 Billion EUR | -0.95% |
| 2015 | 2.11 Billion EUR | 16.04% |
| 2014 | 1.82 Billion EUR | 369.33% |
| 2013 | 388 Million EUR | 51.98% |
| 2012 | 255.29 Million EUR | -51.41% |
| 2011 | 525.41 Million EUR | 65.57% |
| 2010 | 317.33 Million EUR | 1655.79% |
| 2009 | -20.39 Million EUR | -114.08% |
| 2008 | 144.88 Million EUR | 163.42% |
| 2007 | -228.42 Million EUR | -69.36% |
| 2006 | -134.88 Million EUR | -127.26% |
| 2005 | 494.78 Million EUR | -8.16% |
| 2004 | 538.76 Million EUR | -12.26% |
| 2003 | 614.03 Million EUR | 74.16% |
| 2002 | 352.57 Million EUR | 2.66% |
| 2001 | 343.43 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 6.24 Billion EUR | 0.0% |
| 2023 Q2 | 10.23 Billion EUR | 0.0% |
| 2023 FY | 9.09 Billion EUR | -12.91% |
| 2023 Q4 | 9.09 Billion EUR | 0.0% |
| 2022 Q2 | 12.15 Billion EUR | 0.0% |
| 2022 FY | 10.44 Billion EUR | -8.58% |
| 2022 Q4 | 10.44 Billion EUR | 0.0% |
| 2021 Q2 | 4.44 Billion EUR | 0.0% |
| 2021 FY | 11.42 Billion EUR | 58.48% |
| 2021 Q4 | 11.42 Billion EUR | 0.0% |
| 2020 Q4 | 7.21 Billion EUR | 0.0% |
| 2020 FY | 7.21 Billion EUR | 57.48% |
| 2020 Q2 | 9.15 Billion EUR | 0.0% |
| 2019 FY | 4.57 Billion EUR | 18.23% |
| 2019 Q2 | 4.75 Billion EUR | 0.0% |
| 2019 Q4 | 4.57 Billion EUR | 0.0% |
| 2018 Q2 | 1.97 Billion EUR | 0.0% |
| 2018 FY | 3.87 Billion EUR | 423.38% |
| 2018 Q4 | 1.93 Billion EUR | 0.0% |
| 2017 Q4 | 1 Billion EUR | 0.0% |
| 2017 FY | 740 Million EUR | -64.64% |
| 2017 Q2 | 2.27 Billion EUR | 0.0% |
| 2016 FY | 2.09 Billion EUR | -0.95% |
| 2016 Q2 | 2.21 Billion EUR | 0.0% |
| 2016 Q4 | 2.09 Billion EUR | 0.0% |
| 2015 FY | 2.11 Billion EUR | 16.04% |
| 2015 Q4 | 2.11 Billion EUR | 0.0% |
| 2015 Q2 | 2.18 Billion EUR | 0.0% |
| 2014 Q2 | 2.18 Billion EUR | 0.0% |
| 2014 Q4 | 1.82 Billion EUR | 0.0% |
| 2014 FY | 1.82 Billion EUR | 369.33% |
| 2013 FY | 388 Million EUR | 51.98% |
| 2013 Q4 | 388 Million EUR | 0.0% |
| 2013 Q2 | 430.82 Million EUR | 0.0% |
| 2012 FY | 255.29 Million EUR | -51.41% |
| 2012 Q2 | 612.33 Million EUR | 859.44% |
| 2012 Q1 | 63.82 Million EUR | -87.85% |
| 2012 Q4 | 255.29 Million EUR | 300.0% |
| 2012 Q3 | 63.82 Million EUR | -89.58% |
| 2011 Q2 | 480.3 Million EUR | 265.66% |
| 2011 FY | 525.41 Million EUR | 65.57% |
| 2011 Q4 | 525.41 Million EUR | 300.0% |
| 2011 Q3 | 131.35 Million EUR | -72.65% |
| 2011 Q1 | 131.35 Million EUR | -58.61% |
| 2010 FY | 317.33 Million EUR | 1655.79% |
| 2010 Q3 | 79.33 Million EUR | -87.66% |
| 2010 Q1 | 79.33 Million EUR | 488.95% |
| 2010 Q4 | 317.33 Million EUR | 300.0% |
| 2010 Q2 | 642.9 Million EUR | 710.38% |
| 2009 Q3 | -5.09 Million EUR | 0.0% |
| 2009 FY | -20.39 Million EUR | -114.08% |
| 2009 Q4 | -20.39 Million EUR | -300.0% |
| 2009 Q2 | -5.09 Million EUR | 0.0% |
| 2009 Q1 | -5.09 Million EUR | -114.08% |
| 2008 Q2 | 36.22 Million EUR | 0.0% |
| 2008 Q1 | 36.22 Million EUR | 163.42% |
| 2008 FY | 144.88 Million EUR | 163.42% |
| 2008 Q3 | 36.22 Million EUR | 0.0% |
| 2008 Q4 | 36.22 Million EUR | 0.0% |
| 2007 Q2 | -57.1 Million EUR | 0.0% |
| 2007 Q1 | -57.1 Million EUR | -69.36% |
| 2007 Q4 | -57.1 Million EUR | 0.0% |
| 2007 FY | -228.42 Million EUR | -69.36% |
| 2007 Q3 | -57.1 Million EUR | 0.0% |
| 2006 Q2 | -33.72 Million EUR | 0.0% |
| 2006 Q3 | -33.72 Million EUR | 0.0% |
| 2006 Q4 | -33.72 Million EUR | 0.0% |
| 2006 Q1 | -33.72 Million EUR | -127.26% |
| 2006 FY | -134.88 Million EUR | -127.26% |
| 2005 Q1 | 123.69 Million EUR | -8.16% |
| 2005 Q2 | 123.69 Million EUR | 0.0% |
| 2005 Q3 | 123.69 Million EUR | 0.0% |
| 2005 Q4 | 123.69 Million EUR | 0.0% |
| 2005 FY | 494.78 Million EUR | -8.16% |
| 2004 FY | 538.76 Million EUR | -12.26% |
| 2004 Q4 | 134.69 Million EUR | 0.0% |
| 2004 Q3 | 134.69 Million EUR | 0.0% |
| 2004 Q2 | 134.69 Million EUR | 0.0% |
| 2004 Q1 | 134.69 Million EUR | -12.26% |
| 2003 Q3 | 153.5 Million EUR | 0.0% |
| 2003 Q1 | 153.5 Million EUR | 74.16% |
| 2003 Q2 | 153.5 Million EUR | 0.0% |
| 2003 Q4 | 153.5 Million EUR | 0.0% |
| 2003 FY | 614.03 Million EUR | 74.16% |
| 2002 FY | 352.57 Million EUR | 2.66% |
| 2002 Q1 | 88.14 Million EUR | 0.0% |
| 2002 Q2 | 88.14 Million EUR | 0.0% |
| 2002 Q4 | 88.14 Million EUR | 0.0% |
| 2002 Q3 | 88.14 Million EUR | 0.0% |
| 2001 FY | 343.43 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Crossject Société Anonyme | 13.88 Million EUR | -65431.149% |
| Safe Orthopaedics SA | 9.13 Million EUR | -99549.546% |
| Spineway SA | 802 Thousand EUR | -1134438.653% |
| Amplitude Surgical SA | 78.54 Million EUR | -11484.0% |
| Sartorius Stedim Biotech S.A. | 3.56 Billion EUR | -155.21% |
| bonyf N.V. | 65.04 Thousand EUR | -13989537.306% |